A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation

Published:2000-01 Issue:1 Volume:6 Page:25-34
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Nash Richard A.,Kurzrock Razelle,DiPersio John,Vose Julie,Linker Charles,Maharaj Dipnarine,Nademanee Auayporn P.,Negrin Robert,Nimer Stephen,Shulman Howard,Ashby Mark,Jones Dennie,Appelbaum Frederick R.,Champlin Richard

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;Transfusion and Apheresis Science;2024-10

2. Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review;ImmunoTargets and Therapy;2024-09

3. Humanized mouse models for inherited thrombocytopenia studies;Platelets;2023-10-17

4. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;2023-08-07

5. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial;Hematological Oncology;2022-05-18